Latest Asset Management News

Alfabs Australia Limited reported robust financial gains in FY2025, including a maiden dividend and major contract completion, while signaling cautious optimism for 2026 amid softer markets and uncertain project pipelines.

MA Financial Group has contracted to acquire Queensland’s Hyperdome Town Centre for $678.7 million, funded by a $405 million equity raise, pushing its proforma assets under management to $14.7 billion. The group also closed a $230 million credit notes raising early due to strong demand.

Viridis Mining and Minerals has locked in a US$30 million strategic funding agreement with Brazilian asset managers Régia Capital and ORE Investments, setting a clear path to Final Investment Decision for its Colossus rare earth project.

Macquarie Asset Management has tabled a $5.20 per share cash offer to acquire Qube Holdings, valuing the logistics giant at approximately $11.6 billion. The Qube board has entered an exclusivity agreement and signals unanimous support, pending due diligence and regulatory approvals.

Aeris Resources reported solid FY25 results within guidance and secured $80 million in new equity to fund exploration and development projects, positioning itself for significant growth in FY26.

Verbrec Limited has announced a transformative acquisition of Alliance Automation, adding over $60 million in annual revenue and significantly boosting its digital and automation capabilities across Australia and New Zealand.

Ragusa Minerals is advancing its acquisition of a majority stake in Pegasus Tel Inc., gaining control of the Purple Pansy manganese-gold project in Arizona, while exiting its Burracoppin tenement to sharpen its focus on US critical minerals.

Alterity Therapeutics announces significant board changes, including the retirement of founding chairman Geoffrey Kempler and appointment of CEO Dr David Stamler as Managing Director, aligning leadership with its Phase 3 clinical ambitions.

Charter Hall Group reported solid FY25 financial results with significant earnings growth and sustainability milestones, while guiding higher earnings and distributions for FY26.

Qube Holdings reported a robust FY25 with significant revenue and earnings growth, strategic acquisitions, and a refreshed board leadership. Despite operational challenges, the company raised its dividend and confirmed solid FY26 earnings guidance.

Associate Global Partners has signed a Memorandum of Understanding with Muzinich & Co. to develop a global private credit fund offering daily liquidity, pending a formal agreement.

Biotron Limited has launched a $1.5 million non-renounceable rights issue to fund its strategic acquisition of Sedarex Limited and support ongoing drug development programs. The capital raise follows shareholder approval and aims to diversify Biotron’s portfolio with a next-generation general anaesthetic.